A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Monday, April 27, 2026
Tag: GE HealthCare Technologies
GE’s Spinoff Deserves Healthy Skepticism
While GE HealthCare will deliver better growth as a stand-alone, the new company’s valuation looks stretched and its leverage is ...
As Rest of IPO Market Stalls, Corporate Carve-Outs Gain Steam
A filing by a J&J unit for a corporate carve-out highlights what some see as a corporate opportunity during soft ...
EDITOR'S PICK
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.